Moreover, CAV-1 deficiency in prostate cancer stromal cells can accelerate tumor growth and reduce relapse-free survival of patients by upregulating Akt phosphorylation, resulting in oncogenic gene expression, including transforming growth factor-β1 (TGF-β1)[24]. Here, TGFB1 is linked to prostate carcinoma.